Cureus , doi: 10.7759/cureus.77998 (2025)
For people drawn to glutathione for its antioxidant support and its popular association with bright, healthy-looking skin, the intramuscular route is a quick and practical way to receive it without setting aside time for a full IV session
Around 40% of patients stopped taking their GLP-1 drug within the first year, rising to nearly 60% by the end of two years
Together, we can translate those insights into future therapy development, innovations in care delivery, and greater patient outcomes," said Brian Bradbury, vice president of Observational Research at Amgen
Not a drug, food, or cosmetic
[2] Additionally, GLP-1 agonists may be prescribed for individuals with type 2 diabetes who have coexisting conditions such as atherosclerosis, heart failure, or chronic kidney disease, as these medications have demonstrated potential benefits beyond glycemic control